Bristol-Myers Squibb
BMY
#195
Rank
NZ$207.38 B
Marketcap
NZ$101.56
Share price
-1.61%
Change (1 day)
35.60%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): NZ$6.10

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is NZ$6.27. In 2025 the company made an earnings per share (EPS) of NZ$6.10 an increase over its 2024 EPS that were of NZ-$7.79.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$6.100.11%
2025NZ$6.10-178.28%
2024NZ-$7.79-213.92%
2023NZ$6.8430.2%
2022NZ$5.25-6.04%
2021NZ$5.59-179.29%
2020NZ-$7.05-281.37%
2019NZ$3.89-27.21%
2018NZ$5.34
2016NZ$4.71175.26%
2015NZ$1.71-19.83%
2014NZ$2.13-22.44%
2013NZ$2.7534.48%
2012NZ$2.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.40 145.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.37 97.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.31-63.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$3.62-42.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$49.75 692.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$25.52 306.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.51-28.10%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$16.48 162.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.27-0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$12.25 95.22%๐Ÿ‡ฌ๐Ÿ‡ง UK